Cell Line Development Strategies that Reduce Timelines & Costs

Access the on-demand recording to hear expert insights on optimizing Cell Line Development (CLD) to accelerate biologics development and improve success rates. Hosted by Biospring Partners’ Socs Zacharias, this webinar covered strategies and technologies that overcome common CLD challenges, ensuring faster and more efficient development timelines.

Abzena’s industry leaders Dr. Campbell Bunce, Chief Scientific Officer, Brett Verstak, Director of Cell Line Development, and ProteoNic’s VP of Business Development, Jonathan Frampton, discussed the critical role of robust CLD strategies and advanced technology platforms. Learn how innovations like AbZelectPRO™, which integrates Abzena’s CHO-K1 cell line with ProteoNic’s 2G UNic® vector technology, can enhance productivity, reduce risks, and accelerate the generation of IND-enabling data.

Why Watch?

Gain actionable insights into integrating innovative CLD technologies, de-risking strategies, and efficient development approaches to maximize the success of your biologics program.